Skip to main content
Erschienen in: Seminars in Immunopathology 1/2016

01.01.2016 | Review

Lupus erythematosus revisited

verfasst von: Annegret Kuhn, Joerg Wenzel, Marc Bijl

Erschienen in: Seminars in Immunopathology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Lupus erythematosus (LE) is a multifactorial autoimmune disease with clinical manifestations of differing severity. The exact pathomechanisms and interactions resulting in the inflammatory and immunological processes of this heterogeneous disease remain elusive. Approaches in the understanding of the pathomechanisms revealed that the clinical expression of LE is predisposed by susceptibility genes and that various environmental factors are responsible for an abnormal immune response. Several studies demonstrated that ultraviolet (UV) light is one of the major factors in the pathogenesis of the disease. Standardized photoprovocation in patients with LE has been shown to be a safe and efficient model for evaluating the underlying pathomechanisms which lead to the production of autoantibodies and immune complexes. In particular, interferons were defined as important players in the early activation of the immune system and were observed to play a specific role in the immunological interface between the innate and the adaptive immune system. Abnormalities or disturbances in the different processes of cell death, such as apoptosis or necrosis, have also been recognized as crucial in the pathogenesis of LE. Although each process is different and characterized by unique features, the processes are interrelated and result in a complex disease.
Literatur
4.
5.
Zurück zum Zitat Balluz L, Philen R, Ortega L, Rosales C, Brock J, Barr D et al (2001) Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol 154:1029–1036PubMedCrossRef Balluz L, Philen R, Ortega L, Rosales C, Brock J, Barr D et al (2001) Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol 154:1029–1036PubMedCrossRef
9.
Zurück zum Zitat Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82:299–308. doi:10.1097/01.md.0000091181.93122.55 CrossRef Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82:299–308. doi:10.​1097/​01.​md.​0000091181.​93122.​55 CrossRef
10.
Zurück zum Zitat Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (1999) Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 78:167–175CrossRef Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (1999) Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 78:167–175CrossRef
11.
Zurück zum Zitat Jimenez S, Cervera R, Ingelmo M, Font J (2004) The epidemiology of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Berlin, pp 45–52 Jimenez S, Cervera R, Ingelmo M, Font J (2004) The epidemiology of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Berlin, pp 45–52
15.
Zurück zum Zitat Kuhn A, Böhm M, Luger TA (2010) Tissue injury and the skin. In: Lahita R, Buyon J, Koike T (eds) Systemic lupus erythematosus, 5th edn. Elsevier, New York, pp 475–490 Kuhn A, Böhm M, Luger TA (2010) Tissue injury and the skin. In: Lahita R, Buyon J, Koike T (eds) Systemic lupus erythematosus, 5th edn. Elsevier, New York, pp 475–490
20.
Zurück zum Zitat Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4:471–475PubMedCrossRef Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4:471–475PubMedCrossRef
22.
Zurück zum Zitat Provost TT (2004) Nonspecific cutaneous manifestations of systemic lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Heidelberg, pp 93–106 Provost TT (2004) Nonspecific cutaneous manifestations of systemic lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Heidelberg, pp 93–106
24.
Zurück zum Zitat Kuhn A, Ruzicka T (2004) Classification of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Berlin, pp 53–58 Kuhn A, Ruzicka T (2004) Classification of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Berlin, pp 53–58
25.
Zurück zum Zitat Wenzel J, Tuting T (2008) An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in “interface dermatitis”. J Investig Dermatol 128:2392–2402. doi:10.1038/jid.2008.96 PubMedCrossRef Wenzel J, Tuting T (2008) An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in “interface dermatitis”. J Investig Dermatol 128:2392–2402. doi:10.​1038/​jid.​2008.​96 PubMedCrossRef
26.
Zurück zum Zitat Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T et al (2005) Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 205:435–442. doi:10.1002/path.1721 PubMedCrossRef Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T et al (2005) Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 205:435–442. doi:10.​1002/​path.​1721 PubMedCrossRef
28.
Zurück zum Zitat Lipsker D (2006) Classification of specific cutaneous manifestations in patients with lupus erythematosus: a time for change? The concept of dermal lupus erythematosus. Dermatology 212:324–326. doi:10.1159/000092282 PubMedCrossRef Lipsker D (2006) Classification of specific cutaneous manifestations in patients with lupus erythematosus: a time for change? The concept of dermal lupus erythematosus. Dermatology 212:324–326. doi:10.​1159/​000092282 PubMedCrossRef
29.
Zurück zum Zitat Gonzalez EG, Selvi E, Lorenzini S, Maggio R, Mannucci S, Galeazzi M et al (2007) Subcutaneous panniculitis-like T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis. Clin Rheumatol 26:244–246. doi:10.1007/s10067-005-0125-x PubMedCrossRef Gonzalez EG, Selvi E, Lorenzini S, Maggio R, Mannucci S, Galeazzi M et al (2007) Subcutaneous panniculitis-like T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis. Clin Rheumatol 26:244–246. doi:10.​1007/​s10067-005-0125-x PubMedCrossRef
30.
31.
Zurück zum Zitat George R, Kurian S, Jacob M, Thomas K (1995) Diagnostic evaluation of the lupus band test in discoid and systemic lupus erythematosus. Int J Dermatol 34:170–173PubMedCrossRef George R, Kurian S, Jacob M, Thomas K (1995) Diagnostic evaluation of the lupus band test in discoid and systemic lupus erythematosus. Int J Dermatol 34:170–173PubMedCrossRef
35.
Zurück zum Zitat Costner MI, Sontheimer RD, Provost TT (2003) Lupus erythematosus. In: Sontheimer RD, Provost TT (eds) Cutaneous manifestations of rheumatic diseases. Williams & Wilkins, Philadelphia, pp 15–64 Costner MI, Sontheimer RD, Provost TT (2003) Lupus erythematosus. In: Sontheimer RD, Provost TT (eds) Cutaneous manifestations of rheumatic diseases. Williams & Wilkins, Philadelphia, pp 15–64
38.
Zurück zum Zitat Sontheimer RD (2005) Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 4:253–263PubMedCrossRef Sontheimer RD (2005) Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 4:253–263PubMedCrossRef
39.
Zurück zum Zitat Milde P, Goerz G (1994) Depigmentierung bei Lupus erythematodes (LE) - Klinischer “Clue” zum subakut kutanen Lupus erythematodes (SCLE). Z Hautkr 69:123–126 Milde P, Goerz G (1994) Depigmentierung bei Lupus erythematodes (LE) - Klinischer “Clue” zum subakut kutanen Lupus erythematodes (SCLE). Z Hautkr 69:123–126
42.
Zurück zum Zitat Helm TN, Jones CM (2002) Chilblain lupus erythematosus lesions precipitated by the cold. Cutis 69:183–184PubMed Helm TN, Jones CM (2002) Chilblain lupus erythematosus lesions precipitated by the cold. Cutis 69:183–184PubMed
43.
Zurück zum Zitat Aringer M, Lee-Kirsch MA, Kuhn A (2012) Chilblain lupus erythematosus. In: Matucci-Cerinic M, Warren P (eds) Rheumatic diseases and the skin. Elsevier, New York, pp 13–19 Aringer M, Lee-Kirsch MA, Kuhn A (2012) Chilblain lupus erythematosus. In: Matucci-Cerinic M, Warren P (eds) Rheumatic diseases and the skin. Elsevier, New York, pp 13–19
45.
47.
Zurück zum Zitat Tomasini D, Mentzel T, Hantschke M, Cerri A, Paredes B, Rutten A et al (2010) Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner’s lymphocytic infiltrate of the skin and cutaneous lupus erythematosus. J Cutan Pathol 37:1132–1139. doi:10.1111/j.1600-0560.2010.01587.x PubMedCrossRef Tomasini D, Mentzel T, Hantschke M, Cerri A, Paredes B, Rutten A et al (2010) Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner’s lymphocytic infiltrate of the skin and cutaneous lupus erythematosus. J Cutan Pathol 37:1132–1139. doi:10.​1111/​j.​1600-0560.​2010.​01587.​x PubMedCrossRef
53.
Zurück zum Zitat Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA (1990) Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Investig Dermatol 94:77–85PubMedCrossRef Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA (1990) Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Investig Dermatol 94:77–85PubMedCrossRef
54.
Zurück zum Zitat Golan TD, Elkon KB, Gharavi AE, Krueger JG (1992) Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 90:1067–1076. doi:10.1172/JCI115922 PubMedPubMedCentralCrossRef Golan TD, Elkon KB, Gharavi AE, Krueger JG (1992) Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 90:1067–1076. doi:10.​1172/​JCI115922 PubMedPubMedCentralCrossRef
55.
56.
Zurück zum Zitat Cazenave P (1851) Lupus erythematoux (erytheme centrifuge). Ann Mal Peau Syph 3:297–299 Cazenave P (1851) Lupus erythematoux (erytheme centrifuge). Ann Mal Peau Syph 3:297–299
57.
Zurück zum Zitat Freund H (1929) Inwiefern ist der Lupus erythematodes von allgemeinen Faktoren abhängig? Dermatol Wochenschr 89:1939–1946 Freund H (1929) Inwiefern ist der Lupus erythematodes von allgemeinen Faktoren abhängig? Dermatol Wochenschr 89:1939–1946
58.
Zurück zum Zitat Fuhs E (1922) Lupus erythematodes subacutus mit ausgesprochener Überempfindlichkeit gegen Quarzlicht. Z Hautkr 30:308–309 Fuhs E (1922) Lupus erythematodes subacutus mit ausgesprochener Überempfindlichkeit gegen Quarzlicht. Z Hautkr 30:308–309
59.
60.
Zurück zum Zitat Pusey W (1915) Attacks of lupus erythematosus following exposure to sunlight or weather factors. Arch Dermatol Syph 33:388 Pusey W (1915) Attacks of lupus erythematosus following exposure to sunlight or weather factors. Arch Dermatol Syph 33:388
63.
65.
66.
Zurück zum Zitat Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686. doi:10.1002/art.34473 PubMedPubMedCentralCrossRef Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686. doi:10.​1002/​art.​34473 PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Hasan T, Stephansson E, Ranki A (1999) Distribution of naive and memory T-cells in photoprovoked and spontaneous skin lesions of discoid lupus erythematosus and polymorphous light eruption. Acta Derm Venereol 79:437–442. doi:10.1080/000155599750009861 PubMedCrossRef Hasan T, Stephansson E, Ranki A (1999) Distribution of naive and memory T-cells in photoprovoked and spontaneous skin lesions of discoid lupus erythematosus and polymorphous light eruption. Acta Derm Venereol 79:437–442. doi:10.​1080/​0001555997500098​61 PubMedCrossRef
77.
78.
Zurück zum Zitat Epstein JH, Tuffanelli D, Dubois EL (1965) Light sensitivity and lupus erythematosus. Arch Dermatol 91:483–485PubMedCrossRef Epstein JH, Tuffanelli D, Dubois EL (1965) Light sensitivity and lupus erythematosus. Arch Dermatol 91:483–485PubMedCrossRef
79.
80.
Zurück zum Zitat Lehmann P, Hölzle E, Kind P, Goerz G, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 22:181–187PubMedCrossRef Lehmann P, Hölzle E, Kind P, Goerz G, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 22:181–187PubMedCrossRef
81.
Zurück zum Zitat Ruland V, Haust M, Stilling RM, Amler S, Ruzicka T, Kuhn A (2013) Updated analysis of standardised photoprovocation in patients with cutaneous lupus erythematosus. Arthritis Care Res 65:767–776. doi:10.1002/acr.21867 CrossRef Ruland V, Haust M, Stilling RM, Amler S, Ruzicka T, Kuhn A (2013) Updated analysis of standardised photoprovocation in patients with cutaneous lupus erythematosus. Arthritis Care Res 65:767–776. doi:10.​1002/​acr.​21867 CrossRef
82.
Zurück zum Zitat Kuhn A, Wozniacka A, Szepietowski JC, Glaser R, Lehmann P, Haust M et al (2011) Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. J Investig Dermatol 131:1622–1630. doi:10.1038/jid.2011.101 PubMedCrossRef Kuhn A, Wozniacka A, Szepietowski JC, Glaser R, Lehmann P, Haust M et al (2011) Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. J Investig Dermatol 131:1622–1630. doi:10.​1038/​jid.​2011.​101 PubMedCrossRef
83.
Zurück zum Zitat Zahn S, Graef M, Patsinakidis N, Landmann A, Surber C, Wenzel J et al (2014) Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus. Exp Dermatol 23:516–518. doi:10.1111/exd.12428 PubMedCrossRef Zahn S, Graef M, Patsinakidis N, Landmann A, Surber C, Wenzel J et al (2014) Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus. Exp Dermatol 23:516–518. doi:10.​1111/​exd.​12428 PubMedCrossRef
84.
Zurück zum Zitat Patsinakidis N, Wenzel J, Landmann A, Koch R, Gerss J, Luger TA et al (2012) Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls. Exp Dermatol 21:958–961. doi:10.1111/exd.12035 PubMedCrossRef Patsinakidis N, Wenzel J, Landmann A, Koch R, Gerss J, Luger TA et al (2012) Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls. Exp Dermatol 21:958–961. doi:10.​1111/​exd.​12035 PubMedCrossRef
86.
Zurück zum Zitat Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58:309–314PubMedPubMedCentralCrossRef Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58:309–314PubMedPubMedCentralCrossRef
87.
Zurück zum Zitat Kuhn A, Herrmann M, Kleber S, Beckmann-Welle M, Fehsel K, Martin-Villalba A et al (2006) Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 54:939–950. doi:10.1002/art.21658 PubMedCrossRef Kuhn A, Herrmann M, Kleber S, Beckmann-Welle M, Fehsel K, Martin-Villalba A et al (2006) Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 54:939–950. doi:10.​1002/​art.​21658 PubMedCrossRef
89.
Zurück zum Zitat Reefman E, de Jong MC, Kuiper H, Jonkman MF, Limburg PC, Kallenberg CG et al (2006) Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? Arthritis Res Ther 8:R156. doi:10.1186/ar2051 PubMedPubMedCentralCrossRef Reefman E, de Jong MC, Kuiper H, Jonkman MF, Limburg PC, Kallenberg CG et al (2006) Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? Arthritis Res Ther 8:R156. doi:10.​1186/​ar2051 PubMedPubMedCentralCrossRef
90.
Zurück zum Zitat Biermann MH, Veissi S, Maueroder C, Chaurio R, Berens C, Herrmann M et al (2014) The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets. Expert Rev Clin Immunol 10:1151–1164. doi:10.1586/1744666X.2014.944162 PubMedCrossRef Biermann MH, Veissi S, Maueroder C, Chaurio R, Berens C, Herrmann M et al (2014) The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets. Expert Rev Clin Immunol 10:1151–1164. doi:10.​1586/​1744666X.​2014.​944162 PubMedCrossRef
92.
Zurück zum Zitat Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F et al (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59. doi:10.1038/ng0598-56 PubMedCrossRef Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F et al (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59. doi:10.​1038/​ng0598-56 PubMedCrossRef
98.
103.
Zurück zum Zitat Li B, Yue Y, Dong C, Shi Y, Xiong S (2014) Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production. Clin Exp Rheumatol 32:705–714PubMed Li B, Yue Y, Dong C, Shi Y, Xiong S (2014) Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production. Clin Exp Rheumatol 32:705–714PubMed
105.
Zurück zum Zitat Monneaux F, Hoebeke J, Sordet C, Nonn C, Briand JP, Maillere B et al (2005) Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog. J Immunol 175:5839–5847PubMedCrossRef Monneaux F, Hoebeke J, Sordet C, Nonn C, Briand JP, Maillere B et al (2005) Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog. J Immunol 175:5839–5847PubMedCrossRef
111.
Zurück zum Zitat Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181PubMedCrossRef Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181PubMedCrossRef
115.
119.
Zurück zum Zitat Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H et al (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487–496. doi:10.1038/ni1457 PubMedCrossRef Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H et al (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487–496. doi:10.​1038/​ni1457 PubMedCrossRef
120.
Zurück zum Zitat Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M et al (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971–981. doi:10.1002/art.10859 PubMedCrossRef Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M et al (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971–981. doi:10.​1002/​art.​10859 PubMedCrossRef
121.
Zurück zum Zitat Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251PubMedCrossRef Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251PubMedCrossRef
123.
Zurück zum Zitat Bald T, Quast T, Landsberg J, Rogava M, Glodde N, Lopez-Ramos D et al (2014) Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507:109–113. doi:10.1038/nature13111 PubMedCrossRef Bald T, Quast T, Landsberg J, Rogava M, Glodde N, Lopez-Ramos D et al (2014) Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507:109–113. doi:10.​1038/​nature13111 PubMedCrossRef
124.
125.
Zurück zum Zitat Shimazaki J, Matsumoto N, Ogura H, Muroya T, Kuwagata Y, Nakagawa J et al (2012) Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury. Shock 37:634–638. doi:10.1097/SHK.0b013e31824ed6b7 PubMedCrossRef Shimazaki J, Matsumoto N, Ogura H, Muroya T, Kuwagata Y, Nakagawa J et al (2012) Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury. Shock 37:634–638. doi:10.​1097/​SHK.​0b013e31824ed6b7​ PubMedCrossRef
126.
127.
128.
Zurück zum Zitat Abdulahad DA, Westra J, Horst G (2011) HMGB1 is an important mediator in cutaneous inflammation in systemic lupus erythematosus (SLE). Arthritis Rheum 63:S649CrossRef Abdulahad DA, Westra J, Horst G (2011) HMGB1 is an important mediator in cutaneous inflammation in systemic lupus erythematosus (SLE). Arthritis Rheum 63:S649CrossRef
129.
Zurück zum Zitat Abdulahad DA, Westra J, Bijzet J, Dolff S, van Dijk MC, Limburg PC et al (2012) Urine levels of HMGB1 in systemic lupus erythematosus patients with and without renal manifestations. Arthritis Res Ther 14:R184. doi:10.1186/ar4015 PubMedPubMedCentralCrossRef Abdulahad DA, Westra J, Bijzet J, Dolff S, van Dijk MC, Limburg PC et al (2012) Urine levels of HMGB1 in systemic lupus erythematosus patients with and without renal manifestations. Arthritis Res Ther 14:R184. doi:10.​1186/​ar4015 PubMedPubMedCentralCrossRef
130.
Zurück zum Zitat Li J, Xie H, Wen T, Liu H, Zhu W, Chen X (2010) Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol 37:766–775. doi:10.3899/jrheum.090663 PubMedCrossRef Li J, Xie H, Wen T, Liu H, Zhu W, Chen X (2010) Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol 37:766–775. doi:10.​3899/​jrheum.​090663 PubMedCrossRef
131.
Zurück zum Zitat Ma CY, Jiao YL, Zhang J, Yang QR, Zhang ZF, Shen YJ et al (2012) Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int 32:395–402. doi:10.1007/s00296-010-1636-6 PubMedCrossRef Ma CY, Jiao YL, Zhang J, Yang QR, Zhang ZF, Shen YJ et al (2012) Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int 32:395–402. doi:10.​1007/​s00296-010-1636-6 PubMedCrossRef
132.
133.
134.
Zurück zum Zitat Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M et al (2005) Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 52:3639–3645. doi:10.1002/art.21398 PubMedCrossRef Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M et al (2005) Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 52:3639–3645. doi:10.​1002/​art.​21398 PubMedCrossRef
135.
Zurück zum Zitat Barkauskaite V, Ek M, Popovic K, Harris HE, Wahren-Herlenius M, Nyberg F (2007) Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus 16:794–802. doi:10.1177/0961203307081895 PubMedCrossRef Barkauskaite V, Ek M, Popovic K, Harris HE, Wahren-Herlenius M, Nyberg F (2007) Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus 16:794–802. doi:10.​1177/​0961203307081895​ PubMedCrossRef
136.
Zurück zum Zitat de Souza AW, van der Geest KS, Brouwer E, Pinheiro FA, Oliveira AC, Sato EI et al (2015) High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins. Arthritis Res Ther 17:158. doi:10.1186/s13075-015-0672-8 PubMedPubMedCentralCrossRef de Souza AW, van der Geest KS, Brouwer E, Pinheiro FA, Oliveira AC, Sato EI et al (2015) High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins. Arthritis Res Ther 17:158. doi:10.​1186/​s13075-015-0672-8 PubMedPubMedCentralCrossRef
141.
Zurück zum Zitat Kalunian KC, Merrill JT, Maciuca R, McBride JM, Townsend MJ, Wei X et al (2015) A phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE). Ann Rheum Dis. doi:10.1136/annrheumdis-2014-206090 Kalunian KC, Merrill JT, Maciuca R, McBride JM, Townsend MJ, Wei X et al (2015) A phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE). Ann Rheum Dis. doi:10.​1136/​annrheumdis-2014-206090
142.
Zurück zum Zitat Petri M, Wallace DJ, Spindler A, Chindalore V, Kalunian K, Mysler E et al (2013) Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study. Arthritis Rheum 65:1011–1021. doi:10.1002/art.37824 PubMedPubMedCentralCrossRef Petri M, Wallace DJ, Spindler A, Chindalore V, Kalunian K, Mysler E et al (2013) Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study. Arthritis Rheum 65:1011–1021. doi:10.​1002/​art.​37824 PubMedPubMedCentralCrossRef
145.
Zurück zum Zitat Conroy M, Sewell L, Miller OF, Ferringer T (2008) Interferon-beta injection site reaction: review of the histology and report of a lupus-like pattern. J Am Acad Dermatol 59:S48–S49PubMedCrossRef Conroy M, Sewell L, Miller OF, Ferringer T (2008) Interferon-beta injection site reaction: review of the histology and report of a lupus-like pattern. J Am Acad Dermatol 59:S48–S49PubMedCrossRef
147.
Zurück zum Zitat Zahn S, Rehkamper C, Ferring-Schmitt S, Bieber T, Tuting T, Wenzel J (2011) Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus. Br J Dermatol 165:1118–1123. doi:10.1111/j.1365-2133.2011.10479.x PubMedCrossRef Zahn S, Rehkamper C, Ferring-Schmitt S, Bieber T, Tuting T, Wenzel J (2011) Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus. Br J Dermatol 165:1118–1123. doi:10.​1111/​j.​1365-2133.​2011.​10479.​x PubMedCrossRef
148.
Zurück zum Zitat Wenzel J, Zahn S, Mikus S, Wiechert A, Bieber T, Tuting T (2007) The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br J Dermatol 157:752–757. doi:10.1111/j.1365-2133.2007.08137.x PubMedCrossRef Wenzel J, Zahn S, Mikus S, Wiechert A, Bieber T, Tuting T (2007) The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br J Dermatol 157:752–757. doi:10.​1111/​j.​1365-2133.​2007.​08137.​x PubMedCrossRef
149.
Zurück zum Zitat Vallin H, Perers A, Alm GV, Ronnblom L (1999) Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 163:6306–6313PubMed Vallin H, Perers A, Alm GV, Ronnblom L (1999) Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 163:6306–6313PubMed
151.
Zurück zum Zitat Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50:1861–1872. doi:10.1002/art.20254 PubMedCrossRef Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50:1861–1872. doi:10.​1002/​art.​20254 PubMedCrossRef
152.
154.
155.
Zurück zum Zitat Gunther C, Meurer M, Stein A, Viehweg A, Lee-Kirsch MA (2009) Familial chilblain lupus-a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1. Dermatology 219:162–166. doi:10.1159/000222430 PubMedCrossRef Gunther C, Meurer M, Stein A, Viehweg A, Lee-Kirsch MA (2009) Familial chilblain lupus-a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1. Dermatology 219:162–166. doi:10.​1159/​000222430 PubMedCrossRef
156.
157.
159.
Zurück zum Zitat Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330PubMedCrossRef Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330PubMedCrossRef
160.
Zurück zum Zitat Toberer F, Sykora J, Gottel D, Hartschuh W, Werchau S, Enk A et al (2013) Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray. Exp Dermatol 22:656–659. doi:10.1111/exd.12216 PubMedCrossRef Toberer F, Sykora J, Gottel D, Hartschuh W, Werchau S, Enk A et al (2013) Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray. Exp Dermatol 22:656–659. doi:10.​1111/​exd.​12216 PubMedCrossRef
161.
Zurück zum Zitat Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P et al (2009) Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 60:1785–1796. doi:10.1002/art.24557 PubMedCrossRef Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P et al (2009) Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 60:1785–1796. doi:10.​1002/​art.​24557 PubMedCrossRef
164.
Metadaten
Titel
Lupus erythematosus revisited
verfasst von
Annegret Kuhn
Joerg Wenzel
Marc Bijl
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Seminars in Immunopathology / Ausgabe 1/2016
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-015-0550-0

Weitere Artikel der Ausgabe 1/2016

Seminars in Immunopathology 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.